Neutralización de la variante delta del SARS-CoV-2 después de la vacunación heteróloga ChAdOx1-S/BNT162b2

Georg Mn Behrens1, Anne Cossmann2, Metodi V Stankov2

  • 1Department for Rheumatology and Immunology, Hannover Medical School, 30625 Hannover, Germany; German Center for Infection Research, Partner Site Hannover-Braunschweig, Hannover, Germany.

Lancet (London, England)
|August 20, 2021
PubMed
Resumen

No abstract available in PubMed .